[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

McGuire, 1986 - Google Patents

" Schizophrenic and affective disorders: Rationale for a biopsychosocial treatment model": Commentary.

McGuire, 1986

Document ID
10492420247327774532
Author
McGuire M
Publication year

External Links

Snippet

In response to AJ Rosen's (see record 1987-35068-001) discussion of a biopsychosocial treatment model for schizophrenic and affective disorders, the present author considers characteristics of medical research and the financing of treatment-related …
Continue reading at psycnet.apa.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE

Similar Documents

Publication Publication Date Title
Orlinsky et al. A generic model of psychotherapy.
EP0377520A3 (en) Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment
Donlon The therapeutic use of diazepam for akathisia.
Bartkó et al. Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.
Weintraub et al. Piroxicam (CP 16171) in rheumatoid arthritis: a controlled clinical trial with novel assessment techniques
McGuire " Schizophrenic and affective disorders: Rationale for a biopsychosocial treatment model": Commentary.
Makanjuola The Nigerian psychiatric patient and his family.
Granacher et al. Droperidol in acute agitation.
Besana Comparison of niaprazine and placebo in pediatric behaviour and sleep disorders: Double-blind clinical trial.
Sweeney et al. Healing a child's spirit through play therapy: A scriptural approach to treating children.
Barranco et al. Treatment of anxiety with oral hydroxyzine: an overview.
Rosen Schizophrenic and affective disorders: Rationale for a biopsychosocial treatment model.
Pollack Clonazepam: a review of open clinical trials.
Hekimian et al. A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients.
Clarke A Double-blind comparison of naproxen against indometacin in osteoarthrosis
Price et al. Lithium-induced akathisia.
Albala et al. Maprotiline-induced hypnopompic hallucinations.
Mueser et al. Development of tolerance to neuroleptic-induced decreases in blink rate.
Siassi et al. Evaluation of the safety and therapeutic effects of lorazepam on long-term use.
Bailine et al. Comparison of IM haloperidol and IM chlorpromazine in the treatment of acutely psychotic patients.
Kukletová et al. Oxazepam to stomatologic patients who do not cooperate.
Johnson On the relevance of animal studies on lithium to the understanding of lithium therapy.
Poggioli et al. Activity of PK 8165 in anxiety induced by dental surgery: A dose-ranging double-blind study.
Deberdt Camazepam versus diazepam: a double-blind trial on psychoneurotic patients.
Sarwer-Foner Schizophrenia 1980: Implications for psychopharmacology.